Globus Medical, Inc.
GMEDNYSEHealthcare● Active
$78.30
$-1.70(-2.13%)
Market Cap$10.6B
P/E Ratio—
52W High$101.4
52W Low$51.79
Globus Medical, Inc.（GMED）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GMED · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.54B | $0.10B | $0.12B | $0.19B | $0.15B |
| Depreciation & Amort. | $0.28B | $0.25B | $0.14B | $0.07B | $0.07B |
| Stock-Based Comp. | $0.05B | $0.05B | $0.05B | $0.03B | $0.03B |
| Change in Working Capital | ($0.08B) | ($0.10B) | ($0.12B) | ($0.11B) | ($0.02B) |
| Net Cash from Operations | $0.75B | $0.52B | $0.24B | $0.18B | $0.28B |
| Investing Activities | |||||
| Capital Expenditure | ($0.16B) | ($0.12B) | ($0.08B) | ($0.07B) | ($0.06B) |
| Purchases of Investments | ($0.11B) | ($0.11B) | ($0.10B) | ($0.42B) | ($0.62B) |
| Sales of Investments | $0.18B | $0.07B | $0.78B | $0.41B | $0.34B |
| Net Cash from Investing | ($0.36B) | ($0.18B) | $0.30B | ($0.11B) | ($0.38B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.30B) | ($0.09B) | ($0.23B) | ($0.14B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | ($0.68B) | ($0.03B) | ($0.23B) | ($0.11B) | $0.05B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.59B | $0.41B | $0.17B | $0.10B | $0.22B |
| FCF Margin %(computed) | 20.03% | 16.08% | 10.53% | 10.21% | 22.90% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Globus Medical, Inc.
关于Globus Medical, Inc.（GMED）现金流量表
Globus Medical, Inc. 2025财年经营活动现金流$0.75B，自由现金流$0.59B（FCF利润率20.03%），资本支出($0.16B)。
常见问题
GMED · 4 问Globus Medical, Inc. 2025财年自由现金流$0.59B，同比up45.3%。
GMED free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10